Skip to content

Author

Yu-Cang He

We have 3 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Integrating Immunogenetics, Single-Cell Transcriptomics, and AI-Assisted Drug Discovery Reveals CXCL10-Associated Immune Remodelling in Breast Cancer.

Breast cancer is a heterogeneous malignancy shaped by genetic alterations and cytokine-mediated immune interactions. However, integrative characterization of cytokine-related regulators using genetic, single-cell, and computational approaches remains limited. This study aimed to identify genetically supported cytokine-...

Han-Mo Wang, Y. Li, Yan-Ming Chen et al. · 0 citations
Oct 2026

A Senescence‐Related Signature for Risk Stratification and Predicted Immunotherapy Response in Breast Cancer: Integrative Pathology and Multi‐Omics Analysis

Cellular senescence exerts context‐dependent effects on breast cancer progression and therapeutic response through dynamic interactions with the tumor microenvironment; however, its pathological manifestations, cellular organization, and clinical significance remain incompletely understood. In this study, we integrated...

Song-Yun Zhao, Zi-Jian Lin, Yan-Ming Chen et al. · 0 citations
Review Open access Sep 2026

ApoE4 as a Therapeutic Target in Epilepsy: From Pathogenic Mechanisms to Precision Medicine

ABSTRACT Background Epilepsy is a heterogeneous central nervous system disorder characterized by recurrent seizures and is frequently accompanied by cognitive and neuropsychiatric comorbidities. Although apolipoprotein E4 (ApoE4) is well established as a genetic risk factor in Alzheimer's disease, its role as a modifie...

Kang Pan, K. Zhu, Y. E et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.